Subscribe
shutterstock_1852891255_marcus_krauss
Marcus Krauss / Shutterstock.com
6 September 2022Big PharmaStaff Writer

Big pharma firm hits back in COVID-19 tech dispute

CureVac accuses Pfizer and its German partner of infringing patented tech in landmark COVID-19 treatment | The pharma giant says that the patents are invalid

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
Moderna hits Pfizer and BioNTech with COVID-19 vaccine patent suit
30 August 2022   Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Americas
Moderna hits Pfizer and BioNTech with COVID-19 vaccine patent suit
30 August 2022   Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.

More on this story

Americas
Moderna hits Pfizer and BioNTech with COVID-19 vaccine patent suit
30 August 2022   Moderna has taken Pfizer and its German partner BioNTech to court, alleging that the pair copied Moderna’s technology when developing their COVID-19 vaccine.
Big Pharma
CureVac sues BioNTech over mRNA technology
7 July 2022   Germany-based CureVac has accused BioNTech of infringing four patents related to messenger ribonucleic acid technology.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB